Endovascular Therapy of Inflammatory Aortic Aneurysms:A Meta-Analysis

Abstract

EVAR of IAA is feasible, excludes the aneurysm effectively, and reduces PAF and renal impairment in most patients with very low periprocedural and midterm mortality and an acceptable reintervention rate.

Inflammatory Abdominal Aortic Aneurysm Endovascular Repair into the Long-Term Follow-Up

“…[9][10][11][19][20][21][22][23][24][25][26] A meta-analysis published in 2005 reported complete PAF regression in 51% of patients, unchanged in 42%, and progression in 7%, concluding that EVAR for IAAA is feasible and reduces PAF. 12 No PAF progression was noted in this series. Conversely, some authors have published unfavorable results in terms of PAF progression.…”

“…Although PAF regression occurred less frequently after EVAR, an advantageous long-term morbidity seems to be associated with this treatment. 12,13 CONCLUSION This series suggests that EVAR for IAAA in the longterm is associated with a positive trend for both PAF and aneurysm diameter reduction. EVAR does not seem to offer any benefits for hydronephrosis, but seems to effectively exclude the aneurysm sac in anatomically suitable patients.…”

“…In a meta-analysis of 46 patients carried out by Puchner et al, technical success was 96%. 12 The Eurostar database 13 in 2005 concluded that technical success of EVAR for IAAA was not significantly different from EVAR for non-IAAA.…”

“…12,13 . This series provides encouraging longterm aneurysm exclusion and rupture prevention results.…”

“…[9][10][11] These results have been confirmed by a meta-analysis and a report from the Eurostar database. 12,13 This retrospective study aims to evaluate the long-term results in terms of aneurysm-related mortality, PAF changes, aneurysm sac evolution, and hydronephrosis progression of IAAA treated with EVAR.…”